A Fully Decentralized Federated Learning Framework for Automated Image Segmentation in Cancer Radiotherapy
Project Number7R21EB030209-02
Former Number1R21EB030209-01A1
Contact PI/Project LeaderYUAN, YADING
Awardee OrganizationCOLUMBIA UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
PROJECT SUMMARY While the recent surge of artificial intelligence (AI) has made remarkable progress in
various image analysis tasks, their performance in a broad range of clinical environment is largely restricted
by the limited generalization capability when being applied to new data, primarily because most models have
been generated using data from a single institution or public datasets with limited training data. Aggregating
data from different institutions could improve model training, but such centralized data sharing is practically
challenging due to various technical, legal, privacy and data ownership barriers. This proposal aims to address
these barriers by developing a novel gossip federated learning (GFL) framework to build an effective AI model
by learning from different data sources without the need of sharing patient data. As compared to the traditional
client/server federated learning such as FedAvg, the proposed framework is fully decentralized in that the
models trained in local datasets will directly communicate to each other in a peer-to-peer manner, making our
method more robust and efficient. We will develop and evaluate the proposed scheme in the task of automated
organ segmentation in CT images for liver and head and neck (H&N) cancer patients treated with radiation
therapy (RT) because accurate, robust and efficient delineation of those organs at risk (OARs) is a clinically
important but technically challenging problem. We hypothesize that the model trained with our framework can
achieve segmentation performance not inferior to a model with data pooled from all the resources. The
dynamics of our recently created healthcare system mimic a diverse multi-institutional environment, which
places us in an ideal setting to systematically evaluate our framework. Our specific aims include: 1) Establish
the GFL-based automated OAR segmentation framework, and develop the supporting software infrastructure;
2) Optimize the GFL-based autosegmentation; 3) Evaluate GFL-based OAR segmentation framework with
400 liver and 400 H&N cancer patients collected from four hospitals within a metropolitan health system. This
proposal addresses two key research priorities for NIBIB: machine learning based segmentation and
approaches that facilitate interoperability among annotations used in image training databases. The success
of this project will substantially increase the number and variety of data for model training without sacrificing
the patient privacy, and thus improve the performance and generalization of the segmentation model on new
data. We will open-source this framework, which may enable a larger scale of multi-institutional collaboration
and could expedite the clinical adoption of AI-driven autosegmentation in RT. More importantly, this framework
provides a flexible and robust solution to the primary barrier of applying AI to the medical domain where
learning on multi-institutional data sharing is impeded by patient privacy concerns, and is expected to have a
catalytic impact on precision medicine by generalizing it to broader applications within medicine where a model
needs to learn across multi-institutional data without sacrificing patient privacy.
Project Summary/Abstract Page 6
Public Health Relevance Statement
PROJECT NARRATIVE This proposal aims to develop a fully decentralized federated learning framework, which
allows to train a powerful artificial intelligence (AI) model by aggregating information from different institutions
without sharing patient data, in order to meet the urgent needs for automated organ segmentation in cancer
radiotherapy. The success of this project will enable the development of accurate, consistent and efficient
segmentation models trained with massive patient data from different institutions, and will expedite the adoption
of AI-driven image segmentation in radiation oncology clinical practice. More importantly, the proposed
framework will provide a flexible and robust solution to the primary barrier of applying AI techniques to the medical
domain where machine learning on multi-institutional data sharing is impeded by patient privacy concerns, and
is expected to have a catalytic impact on precision medicine by generalizing it to broader applications within
medicine where a model needs to learn across multi-institutional data without sacrificing patient privacy.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
621889815
UEI
QHF5ZZ114M72
Project Start Date
15-September-2023
Project End Date
31-August-2025
Budget Start Date
15-September-2023
Budget End Date
31-August-2025
Project Funding Information for 2021
Total Funding
$442,664
Direct Costs
$269,097
Indirect Costs
$173,567
Year
Funding IC
FY Total Cost by IC
2021
National Institute of Biomedical Imaging and Bioengineering
$442,664
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R21EB030209-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R21EB030209-02
Patents
No Patents information available for 7R21EB030209-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R21EB030209-02
Clinical Studies
No Clinical Studies information available for 7R21EB030209-02
News and More
Related News Releases
No news release information available for 7R21EB030209-02
History
No Historical information available for 7R21EB030209-02
Similar Projects
No Similar Projects information available for 7R21EB030209-02